Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19860
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZiemssen, T.-
dc.contributor.authorHobart, J.-
dc.contributor.authorFEYS, Peter-
dc.contributor.authorLinnebank, M.-
dc.contributor.authorGoodman, A.-
dc.contributor.authorMcNeill, M.-
dc.contributor.authorZhong, J.-
dc.contributor.authorMehta, L.-
dc.date.accessioned2015-11-30T15:12:53Z-
dc.date.available2015-11-30T15:12:53Z-
dc.date.issued2015-
dc.identifier.citationEUROPEAN JOURNAL OF NEUROLOGY, 22 (S1), p. 621-621-
dc.identifier.issn1351-5101-
dc.identifier.urihttp://hdl.handle.net/1942/19860-
dc.language.isoen-
dc.publisherWILEY-BLACKWELL-
dc.rights© 2015 European Journal of Neurology-
dc.titleLong-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateJUN, 2015-
local.bibliographicCitation.conferencename1st Congress of the European-Academy-of-Neurology-
local.bibliographicCitation.conferenceplaceBerlin, GERMANY-
dc.identifier.epage621-
dc.identifier.issueS1-
dc.identifier.spage621-
dc.identifier.volume22-
local.format.pages1-
local.bibliographicCitation.jcatM-
dc.description.notes[Ziemssen, T.] Univ Clin Dresden, Dresden, Germany. [Hobart, J.] Univ Plymouth, Peninsula Sch Med, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Hobart, J.] Univ Plymouth, Peninsula Sch Dent, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Feys, P.] Univ Hasselt, Diepenbeek, Belgium. [Linnebank, M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland. [Goodman, A.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA. [McNeill, M.] Biogen Idec Inc, Maidenhead, Berks, England. [Zhong, J.; Mehta, L.] Biogen Idec Inc, Cambridge, MA USA.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000364239000254-
item.contributorZiemssen, T.-
item.contributorHobart, J.-
item.contributorFEYS, Peter-
item.contributorLinnebank, M.-
item.contributorGoodman, A.-
item.contributorMcNeill, M.-
item.contributorZhong, J.-
item.contributorMehta, L.-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
item.fullcitationZiemssen, T.; Hobart, J.; FEYS, Peter; Linnebank, M.; Goodman, A.; McNeill, M.; Zhong, J. & Mehta, L. (2015) Long-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study. In: EUROPEAN JOURNAL OF NEUROLOGY, 22 (S1), p. 621-621.-
crisitem.journal.issn1351-5101-
crisitem.journal.eissn1468-1331-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
selection (34).pdf
  Restricted Access		194.07 kBAdobe PDFView/Open    Request a copy
Show simple item record

Page view(s)

36
checked on Jul 28, 2023

Download(s)

12
checked on Jul 28, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.